Strategic Research

Nutrition, Eumetabolism and Health (IdIBGi)

Our group is a consolidated group ref. 2014-SGR-1480 and belongs to CIBERobn (CIBER Physiopathology of Obesity and Nutrition) group. The main line of research deal with inflammation and chronic metabolic disease. The main sublines are:

  • Inflammation and insulin resistance.
  • Iron metabolism and insulin resistance.
  • Biomarkers of obesity, insulin resistance and type 2 diabetes.
  • Bone as an endocrine organ.
  • Vascular disease and inflammation.
  • Proteomics in adipose tissue.
  • Microbiota, insulin resistance and NASH

Main projects

  • 1.

    PEPPER: Patient Empowerment through Predictive Personalised decision support

    H2020 project. Period 2016 - 2018.

  • 2.

    Study of iron content in adipose tissue, muscle and brain of obese subjects.

    Interaction with gut microbiota composition and efects of weight loss. (FIS 2016). ISCIII. Period 2016 - 2018.



Bioinformatics expertise:

Group Leader:

José Manuel Fernández-Real